Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-10-06

SHOULDER INNOVATIONS, INC. (SI)

CEO Robert Ball was paid $1,202,483 in fiscal year 2025, ↑ up 91.4% from fiscal year 2024 (SEC filing 0001699350-26-000026 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$1,202,483 ↑
Robert Ball total, FY2025
—
CEO pay percentile vs peers
—
CEO-to-median pay ratio
—
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Robert Ball (Chief Executive Officer and Executive Chairman), FY2025 total compensation $1,202,483 (base salary $467,944) [exec_comp, SEC accession 0001699350-26-000026, filed 2026-04-29]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

SI's next annual pay disclosure, estimated April 29, 2027.est. Filing ↗

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Robert Ball$467,944$0$0$494,126$224,613$0$15,800$1,202,483
Chief Executive Officer and Executive Chairman
David Blue364,45500148,238247,101018,977778,771
Chief Customer Experience Officer
Jeffrey Points378,14450,000—98,825181,509—11,338719,816
Chief Financial Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Robert Ball$1,202,483$628,114—↑ +574,369
David Blue778,771———
Jeffrey Points719,816507,812—↑ +212,004

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read SHOULDER INNOVATIONS, INC.'s Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper SI reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

Get the SHOULDER INNOVATIONS, INC. Peer Teardown Report

$1,202,483 Robert Ball total, FY2025

$199

The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.

Data as of October 6, 2026 · Source: 0001699350-26-000026 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

Reports for SI

Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:

Executive Compensation ReportThe free page is the headline figures. The report is every award, peer and vote combined into one document you can hand to a committee.$1,500 →Reverse Peer AnalysisThe free page is the one line. The analysis reads every company that names this one in its own peer group.$299 →Peer Teardown ReportThe free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.$199 →
SIon Velarion Intel, free → The platform reading of this company, beside the same data as a subscription.

Order SI

Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

How we handle your data → Privacy

Companies that benchmark against SI
No companies currently name SI as a compensation peer in their most recent disclosure.

This is the complete answer, not a partial one — the list is never padded.

Get the SHOULDER INNOVATIONS, INC. Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2025 total
Andrew HykesIndependent Director—
Casey TanseyIndependent Director$138,948
Geoff PardoFormer director (through FY2025)$141,032
Kevin SidowIndependent Director$215,993
Matthew AhearnDirector—
Michael CarusiIndependent Director$133,740
Paul BuckmanLead Independent Director$203,528
Richard J. BuchholzIndependent Director$142,073
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Robert BallDirector2026-04-30D10,000$0$0Derivative, Class A CommonForm 4 ↗
Robert BallDirector2026-04-30A10,000224,804CommonForm 4 ↗
Matthew AhearnDirector2026-06-12D15,85619296,185Common, open-market saleForm 4 ↗
Matthew AhearnDirector2026-06-15D2,5001948,148Common, open-market saleForm 4 ↗
Matthew AhearnDirector2026-06-15D1,6441829,922Common, open-market saleForm 4 ↗
Andrew HykesDirector2026-06-26A5,04600RSUForm 4 ↗
Kevin SidowDirector2026-06-26A5,04600RSUForm 4 ↗
Casey TanseyDirector2026-06-26A5,04600RSUForm 4 ↗
Richard J. BuchholzDirector2026-06-26A5,04600RSUForm 4 ↗
Paul BuckmanDirector2026-06-26A5,04600RSUForm 4 ↗
Gilde Healthcare Holding B.V.Greater-than-10% holder2026-07-30D28,24523659,803Common, indirectForm 4 ↗
Gilde Healthcare Holding B.V.Greater-than-10% holder2026-07-31D20,03423455,373Common, indirectForm 4 ↗
Gilde Healthcare Holding B.V.Greater-than-10% holder2026-08-03D10,75123244,155Common, indirectForm 4 ↗
Gilde Healthcare Holding B.V.Greater-than-10% holder2026-08-04D99,812232,272,719Common, indirectForm 4 ↗
Gilde Healthcare Holding B.V.Greater-than-10% holder2026-08-05D7,33823166,132Common, indirectForm 4 ↗
Gilde Healthcare Holding B.V.Greater-than-10% holder2026-08-06D2,0952347,347Common, indirectForm 4 ↗
Matthew AhearnDirector2026-08-14D2,50000CommonForm 4 ↗
Matthew AhearnDirector2026-08-17D8,31420167,101Common, open-market saleForm 4 ↗
Matthew AhearnDirector2026-08-18D12,58621263,493Common, open-market saleForm 4 ↗
Matthew AhearnDirector2026-08-18D1,6002134,211Common, open-market saleForm 4 ↗
Gilde Healthcare Holding B.V.Greater-than-10% holder2026-08-20D3,9002388,140Common, indirectForm 4 ↗
Gilde Healthcare Holding B.V.Greater-than-10% holder2026-08-21D20,51623463,867Common, indirectForm 4 ↗
Gilde Healthcare Holding B.V.Greater-than-10% holder2026-08-24D6812315,404Common, indirectForm 4 ↗
Gilde Healthcare Holding B.V.Greater-than-10% holder2026-08-26D1,1962327,030Common, indirectForm 4 ↗
Robert BallDirector2026-09-14D10,17518187,706Common, open-market saleForm 4 ↗
Robert BallDirector2026-09-14A89,2332187,282CommonForm 4 ↗
Robert BallDirector2026-09-14D89,23300Derivative, Class A CommonForm 4 ↗
Paul BuckmanDirector2026-10-05A1,2752024,990CommonForm 4 ↗
Andrew HykesDirector2026-10-05A6692013,112CommonForm 4 ↗
Kevin SidowDirector2026-10-05A8922017,483CommonForm 4 ↗
Casey TanseyDirector2026-10-05A7332014,367CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
David BlueOPTION2025-04-23——51,795—$148,238
Jeffrey PointsOPTION2025-04-23——34,530—98,825
Robert BallOPTION2025-04-23——172,650—494,126
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
David Blue$0$0$148,2380.0%
Jeffrey Points0098,8250.0%
Robert Ball00494,1260.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Jeffrey PointsOption34,5302.86—
David BlueOption9,3522.48—
Robert BallOption183,4382.1—
Robert BallOption172,6502.86—
Robert BallOption116,7892.48—
Jeffrey PointsOption46,4262.48—
David BlueOption51,7952.86—
05

Incentive-plan design — the Compensation Discussion & Analysis

CEO STI target (% of salary)50%
CEO LTI target (% of salary)—
Independent consultantFW Cook
Clawback policyAdopted in July 2025. Applies to current and former executive officers. Requires recovery of incentive-based compensation erroneously awarded in the event of an accounting restatement due to material noncompliance with financial reporting requirements. Covers compensation granted, earned, or vested based on financial reporting measures received during the applicable three-year period. Recovery may be deemed impractical at Compensation Committee discretion.
Anti-hedgingThe Insider Trading Policy specifically prohibits hedging transactions, engaging in transactions in puts, calls or other derivative securities involving the Company's equity securities, and short sales.
Anti-pledgingTrue
07

CEO pay ratio

Ratio (CEO : median employee)—
CEO total compensation—
Median employee compensation—
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Kevin SidowIndependent · Audit · Compensation (Chair)$49,167$114,990$51,836$0$0$215,993
Paul BuckmanIndependent · Lead Independent Director · Audit · Nominating/Governance (Chair)45,000114,99043,53800203,528
Richard J. BuchholzIndependent · Audit (Chair) · Nominating/Governance27,083114,990—00142,073
Geoff PardoIndependent · Departed during FY26,042114,990—00141,032
Casey TanseyIndependent · Compensation · Nominating/Governance23,958114,990—00138,948
Michael CarusiIndependent · Not standing for re-election18,750114,990—00133,740
Andrew HykesIndependent · Compensation · Newly elected000000
Robert BallEmployee director · Board Chair000—00
Matthew AhearnEmployee director000—00
09

Board fee structure and ownership guideline

Annual cash retainer$45,000
Annual equity retainer$115,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)10,000 / 7,500 / 5,000
Stock ownership guideline—
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$190,000
Equity awards (grant-date value)$689,940
All other compensation$0
Total cost of the board$879,940

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1SHOULDER INNOVATIONS, INC.2025Robert Ball$467,944$0$494,126$224,613$1,202,483

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10d

Frequently asked questions

Who was the highest-paid executive at SHOULDER INNOVATIONS, INC. in fiscal 2025?
As disclosed, Robert Ball (Chief Executive Officer and Executive Chairman) was the highest-paid executive at SHOULDER INNOVATIONS, INC. in fiscal 2025, with total compensation of $1,202,483.
How much does SHOULDER INNOVATIONS, INC. spend in total on board compensation for fiscal 2025?
As disclosed, SHOULDER INNOVATIONS, INC. reported total board compensation of $879,940 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Robert BallDEF 14A2026-04-290001699350-26-000026Section “Summary Compensation Table for 2025 and 2024”. As printed: 1,202,483. Filing ↗machine: r2 · c21 · span 279096–279105
2Section 01, David BlueDEF 14A2026-04-290001699350-26-000026Section “Summary Compensation Table for 2025 and 2024”. As printed: 778,771. Filing ↗machine: r6 · c21 · span 286634–286641
3Section 01, Jeffrey PointsDEF 14A2026-04-290001699350-26-000026Section “Summary Compensation Table for 2025 and 2024”. As printed: 719,816. Filing ↗machine: r4 · c21 · span 282861–282868
4Section 03, David Blue OPTIONDEF 14A2026-04-290001699350-26-000026Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t37 · r6 · c4 · span 285945–285952
5Section 03, Jeffrey Points OPTIONDEF 14A2026-04-290001699350-26-000026Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t37 · r4 · c4 · span 282173–282179
6Section 03, Robert Ball OPTIONDEF 14A2026-04-290001699350-26-000026Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t37 · r2 · c4 · span 278329–278336
7Section 07, pay ratio10-K2026-03-100001699350-26-000011Section “CEO Pay Ratio”. As printed: —. Filing ↗
8Section 08, Kevin SidowDEF 14A2026-04-290001699350-26-000026Section “Director Compensation”. As printed: 215,993. Filing ↗machine: t32 · r6 · c7 · span 246536–246758
9Section 08, Paul BuckmanDEF 14A2026-04-290001699350-26-000026Section “Director Compensation”. As printed: 203,528. Filing ↗machine: t32 · r3 · c7 · span 242099–242321
10Section 08, Richard J. BuchholzDEF 14A2026-04-290001699350-26-000026Section “Director Compensation”. As printed: 142,073. Filing ↗machine: t32 · r2 · c7 · span 240519–240772
11Section 08, Geoff PardoDEF 14A2026-04-290001699350-26-000026Section “Director Compensation”. As printed: 141,032. Filing ↗machine: t32 · r5 · c7 · span 245200–245422
12Section 08, Casey TanseyDEF 14A2026-04-290001699350-26-000026Section “Director Compensation”. As printed: 138,948. Filing ↗machine: t32 · r7 · c7 · span 247874–248096
13Section 08, Michael CarusiDEF 14A2026-04-290001699350-26-000026Section “Director Compensation”. As printed: 133,740. Filing ↗machine: t32 · r4 · c7 · span 243651–243873
14Section 08, Andrew HykesDEF 14A2026-04-290001699350-26-000026Section “Director Compensation”. As printed: 0. Filing ↗
15Section 08, Robert BallDEF 14A2026-04-290001699350-26-000026Section “Director Compensation”. As printed: 0. Filing ↗
16Section 08, Matthew AhearnDEF 14A2026-04-290001699350-26-000026Section “Director Compensation”. As printed: 0. Filing ↗
17Section 02, Robert Ball 2026-04-30Form 42026-04-300002070664-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
18Section 02, Robert Ball 2026-04-30Form 42026-04-300002070664-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
19Section 02, Matthew Ahearn 2026-06-12Form 42026-06-160002070582-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
20Section 02, Matthew Ahearn 2026-06-15Form 42026-06-160002070582-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
21Section 02, Matthew Ahearn 2026-06-15Form 42026-06-160002070582-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
22Section 02, Andrew Hykes 2026-06-26Form 42026-06-290001806431-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
23Section 02, Kevin Sidow 2026-06-26Form 42026-06-290002072468-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
24Section 02, Casey Tansey 2026-06-26Form 42026-06-290001628280-26-046099Insider equity transaction reported since the proxy statement. Filing ↗
25Section 02, Richard J. Buchholz 2026-06-26Form 42026-06-290001737133-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
26Section 02, Paul Buckman 2026-06-26Form 42026-06-290001215243-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
27Section 02, Gilde Healthcare Holding B.V. 2026-07-30Form 42026-08-030001193125-26-330846Insider equity transaction reported since the proxy statement. Filing ↗
28Section 02, Gilde Healthcare Holding B.V. 2026-07-31Form 42026-08-030001193125-26-330846Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, Gilde Healthcare Holding B.V. 2026-08-03Form 42026-08-050001193125-26-335278Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Gilde Healthcare Holding B.V. 2026-08-04Form 42026-08-050001193125-26-335278Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, Gilde Healthcare Holding B.V. 2026-08-05Form 42026-08-070001193125-26-340260Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, Gilde Healthcare Holding B.V. 2026-08-06Form 42026-08-070001193125-26-340260Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, Matthew Ahearn 2026-08-14Form 42026-08-180002070582-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Matthew Ahearn 2026-08-17Form 42026-08-180002070582-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Matthew Ahearn 2026-08-18Form 42026-08-180002070582-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Matthew Ahearn 2026-08-18Form 42026-08-180002070582-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Gilde Healthcare Holding B.V. 2026-08-20Form 42026-08-240001193125-26-363913Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Gilde Healthcare Holding B.V. 2026-08-21Form 42026-08-240001193125-26-363913Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Gilde Healthcare Holding B.V. 2026-08-24Form 42026-08-240001193125-26-363913Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Gilde Healthcare Holding B.V. 2026-08-26Form 42026-08-280001193125-26-374359Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Robert Ball 2026-09-14Form 42026-09-140002070664-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Robert Ball 2026-09-14Form 42026-09-140002070664-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Robert Ball 2026-09-14Form 42026-09-140002070664-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Paul Buckman 2026-10-05Form 42026-10-060001215243-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Andrew Hykes 2026-10-05Form 42026-10-060001806431-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Kevin Sidow 2026-10-05Form 42026-10-060002072468-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Casey Tansey 2026-10-05Form 42026-10-060001628280-26-065260Insider equity transaction reported since the proxy statement. Filing ↗
48Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
49Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
50Section 09b board cost (computed)Computed——Cash 190,000 + equity 689,940 + all other 0 = 879,940, summed across the director compensation table rows.machine: formula: Σ = 879,940
51SHOULDER INNOVATIONS, INC. (subject), Section 10b CEO totalDEF 14A2026-04-290001699350-26-000026CEO total compensation as printed in SHOULDER INNOVATIONS, INC.'s own proxy. As printed: 1,202,483. Filing ↗machine: r2 · c21 · span 279096–279105

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.

Get the SHOULDER INNOVATIONS, INC. Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
SI Peer Teardown Report